ONCS Oncosec Medical Inc

OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer.

$4.61
As of 04/13/2021     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/31/2011
Outstanding shares:  37,159,684
Average volume:  168,212
Market cap:   $172,049,337
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    68234L306
ISIN:        US68234L3069
Sedol:      BJJP031
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   3.51
PS ratio:   0.00
Return on equity:   -88.88%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy